Americas · Regional markets · Financial Post
Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research
Announced at ESMO 2026: $200,000 in matched funding to advance the future of Canadian breast cancer survivorship. TORONTO — Breast Cancer Canada and AstraZeneca Canada are…
Read the full article on Financial Post Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (financialpost.com)